Which big pharma stock performed best of all in 2016? None other than one of the oldest of them all -- Johnson & Johnson (NYSE: JNJ). The company's shares gained nearly 15% last year, enough to beat out the other top …
There seems to be an overwhelming amount of uncertainty in the markets these days, which is why I believe it’s time to revisit Johnson & Johnson (NYSE:JNJ) stock. Most investors buying Johnson & Johnson.
Johnson & Johnson (JNJ) engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and …
Johnson & Johnson
Pfizer Inc. (ticker: PFE) and Johnson & Johnson (JNJ) are two of the largest health care stocks and drugmakers in the world, each with a market capitalization north of $200 billion. Both of their shares are up over the past …
The healthcare sector is loaded with great dividend stocks. This should not come as a surprise, since healthcare stocks are stable, and generate reliable profits each year. With their consistent earnings growth, healthcare …
Johnson & Johnson
Johnson & Johnson‘s (NYSE:JNJ) stock has barely moved following its Q2 2015 earnings announcement, as there was nothing unexpected or groundbreaking. Currency headwinds were a dampener in otherwise what …
Johnson & Johnson (NYSE:JNJ) beat the analysts’ sales and earnings estimates as it reported results for the first quarter of its fiscal year 2015, on Tuesday. However, the announcement of the better-than-expected …
There are plenty of investors that are afraid right now. Whether they fear the impact of the election or a Fed move on interest rates or something else it has led to a lot of money sitting on the sidelines. As a market technician …
BABY stock generated a golden cross in August 2016. A golden cross is a bullish signal that is produced when a faster 50-day moving average (highlighted in blue) crosses above a slower 200-day moving average (highlighted …